In the meantime, the terms CHIP and ARCH are used interchangeably and both are frequently diagnosed pre-phases of hematologic neoplasms, with a relatively low risk of progression of 0.5% to 1% per year on average [5,6]. The gene discussed is STUB1; the disease is hematopoietic and lymphoid system neoplasm.